NYSE: CNC | Healthcare / Healthcare Plans / USA |
72.83 | -2.31 | -3.07% | Vol 3.93M | 1Y Perf -4.67% |
Feb 2nd, 2023 12:20 DELAYED |
BID | 72.82 | ASK | 72.85 | ||
Open | 74.60 | Previous Close | 75.14 | ||
Pre-Market | 74.99 | After-Market | - | ||
-0.15 -0.20% | - - |
Target Price | 100.00 | Analyst Rating | Strong Buy 1.50 | |
Potential % | 37.52 | Finscreener Ranking | ★★★+ 50.35 | |
Insiders Trans % 3/6/12 mo. | -100/-25/-80 | Value Ranking | ★+ 44.83 | |
Insiders Value % 3/6/12 mo. | -100/-17/-82 | Growth Ranking | ★★★+ 55.27 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-16/-83 | Income Ranking | — - | |
Price Range Ratio 52W % | -1.44 | Earnings Rating | Buy | |
Market Cap | 41.24B | Earnings Date | 7th Feb 2023 | |
Alpha | 0.01 | Standard Deviation | 0.09 | |
Beta | 0.48 |
Today's Price Range 72.1174.60 | 52W Range 73.2098.53 | 5 Year PE Ratio Range 14.0032.40 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | -1.92% | ||
1 Month | -8.38% | ||
3 Months | -11.66% | ||
6 Months | -19.47% | ||
1 Year | -4.67% | ||
3 Years | 19.63% | ||
5 Years | 44.85% | ||
10 Years | 586.21% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 6.18 | |||
ROE last 12 Months | 8.43 | |||
ROA (5Y Avg) | 1.17 | |||
ROA last 12 Months | 2.74 | |||
ROC (5Y Avg) | 6.43 | |||
ROC last 12 Months | 5.24 | |||
Return on invested Capital Q | 1.81 | |||
Return on invested Capital Y | 1.56 | |||
Assets Turnover | 1.50 | |||
Receivables Turnover | 9.00 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
22.90 | ||||
1.76 | ||||
0.40 | ||||
5.40 | ||||
6.40 | ||||
14.47 | ||||
-20.39 | ||||
44.82 | ||||
48.93B | ||||
Forward PE | 11.81 | |||
PEG | 1.71 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.00 | ||||
1.10 | ||||
0.45 | ||||
0.85 | ||||
5.00 | ||||
Leverage Ratio | 3.10 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
5.50 | ||||
2.30 | ||||
3.40 | ||||
2.30 | ||||
1.30 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
108.99B | ||||
192.47 | ||||
24.36 | ||||
24.58 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2022 | 1.22 | 1.30 | 6.56 |
Q02 2022 | 1.73 | 1.77 | 2.31 |
Q01 2022 | 1.68 | 1.83 | 8.93 |
Q04 2021 | 0.98 | 1.01 | 3.06 |
Q03 2021 | 1.29 | 1.26 | -2.33 |
Q02 2021 | 1.41 | 1.25 | -11.35 |
Q01 2021 | 1.65 | 1.63 | -1.21 |
Q04 2020 | 0.45 | 0.46 | 2.22 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2022 QR | 0.87 | 0.00 | - |
12/2022 FY | 5.72 | 0.35 | Positive |
3/2023 QR | 2.32 | 14.29 | Positive |
12/2023 FY | 6.32 | 0.32 | Positive |
Next Report Date | 7th Feb 2023 |
Estimated EPS Next Report | 0.87 |
Estimates Count | 8 |
EPS Growth Next 5 Years % | 13.40 |
Volume Overview | |
---|---|
Volume | 3.93M |
Shares Outstanding | 566.26K |
Shares Float | 518.48M |
Trades Count | 35.98K |
Dollar Volume | 286.86M |
Avg. Volume | 3.60M |
Avg. Weekly Volume | 3.72M |
Avg. Monthly Volume | 3.70M |
Avg. Quarterly Volume | 3.40M |
Centene Corporation (NYSE: CNC) stock closed at 75.14 per share at the end of the most recent trading day (a -1.44% change compared to the prior day closing price) with a volume of 3.84M shares and market capitalization of 41.24B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 71300 people. Centene Corporation CEO is Michael F. Neidorff.
The one-year performance of Centene Corporation stock is -4.67%, while year-to-date (YTD) performance is -8.38%. CNC stock has a five-year performance of 44.85%. Its 52-week range is between 73.195 and 98.53, which gives CNC stock a 52-week price range ratio of -1.44%
Centene Corporation currently has a PE ratio of 22.90, a price-to-book (PB) ratio of 1.76, a price-to-sale (PS) ratio of 0.40, a price to cashflow ratio of 5.40, a PEG ratio of 2.32, a ROA of 2.74%, a ROC of 5.24% and a ROE of 8.43%. The company’s profit margin is 1.30%, its EBITDA margin is 3.40%, and its revenue ttm is $108.99 Billion , which makes it $192.47 revenue per share.
Of the last four earnings reports from Centene Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.87 for the next earnings report. Centene Corporation’s next earnings report date is 07th Feb 2023.
The consensus rating of Wall Street analysts for Centene Corporation is Strong Buy (1.5), with a target price of $100, which is +37.52% compared to the current price. The earnings rating for Centene Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Centene Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Centene Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 7.38, ATR14 : 1.86, CCI20 : -82.87, Chaikin Money Flow : -0.27, MACD : -1.47, Money Flow Index : 45.26, ROC : -2.47, RSI : 39.26, STOCH (14,3) : 12.29, STOCH RSI : 0.54, UO : 37.06, Williams %R : -87.71), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Centene Corporation in the last 12-months were: Christopher J. Coughlin (Buy at a value of $976 440), H. James Dallas (Buy at a value of $250 564), Lori J. Robinson (Sold 1 200 shares of value $111 324 ), Mark J. Brooks (Sold 3 690 shares of value $305 200 ), Richard A. Gephardt (Sold 18 000 shares of value $1 517 060 ), Shannon Bagley (Sold 17 000 shares of value $1 477 810 ), Theodore R. Samuels (Buy at a value of $507 494)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. After acquiring WellCare in early 2020, Centene now serves 21 million medical members, mostly in Medicaid (14 million), Medicare Advantage (1 million total), the individual exchanges (2 million), and other plans (4 million), including Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
CEO: Michael F. Neidorff
Telephone: +1 314 725-4477
Address: 7700 Forsyth Boulevard, St. Louis 63105, MO, US
Number of employees: 71 300
Mon, 19 Dec 2022 14:20 GMT Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Staar Surgical (STAA)
- TipRanks. All rights reserved.Wed, 27 Jul 2022 12:45 GMT Analysts Are Bullish on Top Healthcare Stocks: Centene (CNC), Replimune Group (REPL)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.